Furthermore, our analysis revealed significant immune microenvironment differences between risk groups, with the low-risk group showing higher immune and stromal scores, particularly increased infiltration of CD8+ T cells and M2 macrophages, suggesting stronger anti-tumor immune responses. This evidence concerns the gene CD8A and neoplasm.